The Role of Early Molecular Response in the Management of Chronic Phase CML

Current Hematologic Malignancy Reports - United States
doi 10.1007/s11899-017-0375-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of Early-Phase Design—Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Impact of Early Molecular Response in Children With Chronic Myeloid Leukemia Treated in the French Glivec Phase 4 Study

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Early Molecular and Cytogenetic Response Is Predictive for Long-Term Progression-Free and Overall Survival in Chronic Myeloid Leukemia (CML)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

The Role of Jak2 Inhibitors in the Management of Cml: Can We Rest the Case?

Science Proceedings
2014English

G417(P) Droplet Digital Polymerase Chain Reaction (Ddpcr) Assessment of Deep Molecular Response in Chronic Myeloid Leukaemia (Cml)

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2015English

Study to Assess the Pathophysiological Role of VEGF in Patients With Chronic Myeloid Leukemia(CML)

International Journal of Medical Science and Public Health
2013English

The Role of Early-Phase Design—Letter

Clinical Cancer Research
Cancer ResearchOncology
2019English

PSY12 the Cost of Treating Chronic Myeloid Leukemia (CML) in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Disease Management and Treatment of Chronic Myeloid Leukemia (CML): Experience From the Patient (Pt) Perspective.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy